{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:15:15Z","timestamp":1790154915846,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013778","name":"Aja University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.micpath.2020.104435","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:43:43Z","timestamp":1596627823000},"page":"104435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB\/c mice"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-7217","authenticated-orcid":false,"given":"Masoud","family":"Foroutan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-8477","authenticated-orcid":false,"given":"Mohammad","family":"Barati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-8214","authenticated-orcid":false,"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104435_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"The history of Toxoplasma gondii--the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.micpath.2020.104435_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vetpar.2019.04.012","article-title":"The global seroprevalence of Toxoplasma gondii in pigs: a systematic review and meta-analysis","volume":"269","author":"Foroutan","year":"2019","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2020.104435_bib3","first-page":"147","article-title":"Sur une infection \u00e0 corps de Leishman (ou organismes voisins) du gondi","author":"Nicolle","year":"1908","journal-title":"C. R. Acad. Sci."},{"key":"10.1016\/j.micpath.2020.104435_bib4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cmi.2020.01.008","article-title":"Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis","volume":"26","author":"Rostami","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2020.104435_bib5","first-page":"389","article-title":"Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2020.104435_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tmrv.2016.03.002","article-title":"Toxoplasmosis in blood donors: a systematic review and meta-analysis","volume":"30","author":"Foroutan-Rad","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.micpath.2020.104435_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0049475518801618","article-title":"Screening of toxoplasmosis in cancer patients: a concern","volume":"49","author":"Abdoli","year":"2019","journal-title":"Trop. Doct."},{"key":"10.1016\/j.micpath.2020.104435_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.micpath.2020.104435_bib9","first-page":"193","article-title":"Congenital toxoplasmosis treatment","volume":"15","author":"Serranti","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2020.104435_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis-Searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2020.104435_bib11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1586\/14760584.2015.1098539","article-title":"Recent advances in developing vaccines against Toxoplasma gondii: an update","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104435_bib12","first-page":"259","article-title":"Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii","volume":"18","author":"Foroutan","year":"2019","journal-title":"EXCLI J."},{"key":"10.1016\/j.micpath.2020.104435_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as Toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.micpath.2020.104435_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7774\/cevr.2018.7.2.93","article-title":"Recent progress in microneme-based vaccines development against Toxoplasma gondii","volume":"7","author":"Foroutan","year":"2018","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.micpath.2020.104435_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7774\/cevr.2018.7.1.24","article-title":"Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine","volume":"7","author":"Foroutan","year":"2018","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.micpath.2020.104435_bib16","first-page":"632424","article-title":"Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis","volume":"2008","author":"Dlugonska","year":"2008","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.micpath.2020.104435_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.mib.2007.09.013","article-title":"Rhoptries: an arsenal of secreted virulence factors","volume":"10","author":"Bradley","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2020.104435_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1462-5822.2007.00909.x","article-title":"Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction","volume":"9","author":"Dubremetz","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.micpath.2020.104435_bib19","doi-asserted-by":"crossref","first-page":"104079","DOI":"10.1016\/j.micpath.2020.104079","article-title":"Structural predication and antigenic analysis of ROP16 protein utilizing immunoinformatics methods in order to identification of a vaccine against Toxoplasma gondii: an in silico approach","volume":"142","author":"Ghaffari","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2020.104435_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.meegid.2018.04.033","article-title":"Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii","volume":"62","author":"Foroutan","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2020.104435_bib21","doi-asserted-by":"crossref","first-page":"34245","DOI":"10.1074\/jbc.M504158200","article-title":"Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii","volume":"280","author":"Bradley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2020.104435_bib22","doi-asserted-by":"crossref","first-page":"101413","DOI":"10.1016\/j.cimid.2020.101413","article-title":"Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice","volume":"69","author":"Foroutan","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104435_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00436-012-2852-7","article-title":"Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii","volume":"111","author":"Khosroshahi","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2020.104435_bib24","first-page":"392","article-title":"Expression of plasmid encoded GRA4 gene of Toxoplasma gondii RH strain in CHO eukaryotic cells","volume":"13","author":"Aghdasi","year":"2018","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104435_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3103\/S0891416819010099","article-title":"Evaluation of anti-Toxoplasma gondii immune responses in BALB\/c mice induced by DNA vaccines encoding surface antigen 1 (SAG1) and 3 (SAG3)","volume":"34","author":"Sobati","year":"2019","journal-title":"Mol. Genet. Microbiol. Virol."},{"key":"10.1016\/j.micpath.2020.104435_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3181\/00379727-104-25975","article-title":"Adaptation of orbital bleeding technic to rapid serial blood studies","volume":"104","author":"Riley","year":"1960","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.micpath.2020.104435_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12419","article-title":"Evaluation of the immune response in BALB\/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii","volume":"39","author":"Ahmadpour","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exppara.2014.02.016","article-title":"Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis","volume":"139","author":"Chen","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104435_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pim.12306","article-title":"Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii","volume":"38","author":"Wang","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib30","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/CVI.00397-12","article-title":"Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice","volume":"19","author":"Wang","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00312-10","article-title":"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice","volume":"18","author":"Yuan","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1051\/parasite\/2016004","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice","volume":"23","author":"Wang","year":"2016","journal-title":"Parasite"},{"key":"10.1016\/j.micpath.2020.104435_bib33","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104435_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.actatropica.2017.09.007","article-title":"Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice","volume":"176","author":"Yang","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2020.104435_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104435_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbaexp.2003.11.005","article-title":"Intramuscular plasmid DNA electrotransfer: biodistribution and degradation","volume":"1676","author":"Bureau","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.micpath.2020.104435_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104435_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4049\/jimmunol.165.2.628","article-title":"Cutting edge: IL-12 is required for the maintenance of IFN-\u03b3 production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii","volume":"165","author":"Yap","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2020.104435_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.exppara.2008.03.005","article-title":"Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine","volume":"119","author":"Xue","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104435_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00436-007-0465-3","article-title":"Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice","volume":"101","author":"Zhang","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2020.104435_bib42","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii","volume":"68","author":"Sayles","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2020.104435_bib43","first-page":"17","article-title":"T-cell immunity in human chronic toxoplasmosis","volume":"41","author":"El-Kady","year":"2011","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.micpath.2020.104435_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/intimm\/dxy004","article-title":"Host immune responses to Toxoplasma gondii","volume":"30","author":"Sasai","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micpath.2020.104435_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2020.104435_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2020.104435_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3024.2008.01025.x","article-title":"Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice","volume":"30","author":"Cui","year":"2008","journal-title":"Parasite Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020308019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020308019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:39:54Z","timestamp":1760110794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020308019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":47,"alternative-id":["S0882401020308019"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104435","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104435"}}